HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study

Donn Colby, Kriengkrai Srithanaviboonchai, Suphak Vanichseni, Sumet Ongwandee, Nittaya Phanuphak, Michael Martin, Kachit Choopanya, Suwat Chariyalertsak, Frits van Griensven, Donn Colby, Kriengkrai Srithanaviboonchai, Suphak Vanichseni, Sumet Ongwandee, Nittaya Phanuphak, Michael Martin, Kachit Choopanya, Suwat Chariyalertsak, Frits van Griensven

Abstract

Introduction: Pre-exposure prophylaxis (PrEP) is recommended by the World Health Organization as an effective method of HIV prevention for individuals at risk for infection. In this paper, we describe the unique role that Thailand has played in the global effort to combat the HIV epidemic, including its role in proving the efficacy of PrEP, and discuss the opportunities and challenges of implementing PrEP in a middle-income country.

Discussion: Thailand was one of the first countries in the world to successfully reverse a generalized HIV epidemic. Despite this early success, HIV prevalence has remained high among people who inject drugs and has surged among men who have sex with men (MSM) and transgender women (TGW). Two pivotal trials that showed that the use of oral antiretroviral medication as PrEP can reduce HIV transmission were conducted partially or entirely at Thai sites. Demonstration projects of PrEP, as well as clinical trials of alternative PrEP regimens, began or will begin in 2014-2015 in Thailand and will provide additional data and experience on how to best implement PrEP for high-risk individuals in the community. Financing of drug costs, the need for routine laboratory monitoring and lack of awareness about PrEP among at-risk groups all present challenges to the wider implementation of PrEP for HIV prevention in Thailand.

Conclusions: Although significant challenges to wider use remain, PrEP holds promise as a safe and highly effective method to be used as part of a combined HIV prevention strategy for MSM and TGW in Thailand.

Keywords: HIV; PrEP; Thailand; prevention; prophylaxis.

Figures

Figure 1
Figure 1
Annual new HIV infections in Thailand by risk category, 1988–2015. Adapted from Ref. [12].

References

    1. National Statistics Office. The 2010 population and housing census. Bangkok: National Statistics Office; 2011.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS) HIV in Asia and the Pacific. Geneva: UNAIDS; 2013.
    1. van Griensven F, Phanuphak N, Srithanaviboonchai K. Biomedical HIV prevention research and epidemic control in Thailand: two sides of the same coin. Sex Health. 2014;11(2):180–99.
    1. Royal Thai Army. Results of biannual HIV surveillance among Thai military recruits, 1989–2012. Bangkok: Pramongkutklao College of Medicine; 2013.
    1. Ministry of Public Health. Results of sentinel HIV surveillance in Thailand. Round 1–30, 1988–2012. Nonthaburi: Bureau of Epidemiology, Department of Disease Control Ministry of Public Health; 2012.
    1. Rojanapithayakorn W. The 100% condom use programme in Asia. Reprod Health Matters. 2006;14:41–52. doi: 10.1016/S0968-8080(06)28270-3.
    1. Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS. 1996;10:1–7. doi: 10.1097/00002030-199601000-00001.
    1. The World Bank. Thailand's response to AIDS: building on success, confronting the future. Washington, DC: Thailand Social Monitor V; 2000.
    1. Punpanich W, Ungchusak K, Detels R. Thailand's response to the HIV epidemic. Yesterday, today and tomorrow. AIDS Educ Prev. 2004;16:119–36. doi: 10.1521/aeap.16.3.5.119.35520.
    1. World Health Organization (WHO) Experiences of the 100% condom use program in selected countries in Asia. Manila: WHO; 2004.
    1. Thai National AIDS Committee. Thailand ending AIDS: 2014 Thailand AIDS response progress report. Bangkok: Ministry of Health; 2014.
    1. Thai Working Group for HIV/AIDS Projections. Projection for HIV/AIDS in Thailand 2010–2030. Bangkok: Ministry of Public Health; 2010.
    1. van Griensven F, Thanprasertsuk W, Jommaroeng R, Mansergh G, Naorat S, Jenkins RA, et al. Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS. 2005;19:521–6. doi: 10.1097/01.aids.0000162341.50933.e8.
    1. van Griensven F, Varangrat A, Wimolsate W, Tappero JW, Sinthuwattanawibol C, McNicholl JM, et al. HIV prevalence among populations of men who have sex with men-Thailand, 2003 and 2005. Morb Mortal Wkly Rep. 2006;31:844–8.
    1. Guadamuz TE, Wimonsate W, Varangrat A, Phanuphak P, Jommaroeng R, McNicholl JM, et al. HIV prevalence, risk behavior, hormone use, surgical history and HIV infection among transgender persons in Thailand. AIDS Behav. 2011;15:650–8. doi: 10.1007/s10461-010-9850-5.
    1. van Griensven F, Varangrat A, Wimonsate W, Tanpradech S, Kladsawad K, Chemnasiri T, et al. Trends in HIV prevalence, estimated HIV incidence and risk behavior among men who have sex with men in Bangkok, Thailand, 2003–2007. J Acquir Immune Defic Syndr. 2010;53:234–9.
    1. Bureau of Epidemiology. Results of venue-based HIV surveillance among men who have sex with men in Thailand, 2012. Nonthaburi: Ministry of Public Health, Department of Disease Control; 2012. [In Thai]
    1. Chariyalertsak S, Kosachunhanan N, Saokhieo P, Songsupa R, Wongthanee A, Chariyalertsak C, et al. HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand. PLoS One. 2011;6:24295. doi: 10.1371/journal.pone.0024295.
    1. Nitayaphan S, Benenson M, Sriplienchan S, Morgan P, Eamsila C, Chiu J, et al. ECHO Study (Early Capture HIV Cohort): efficient detection of acute HIV-1 infections in Pattaya, Thailand (RV 217) 2010. Abstracts from AIDS Vaccine; 28 September–1 October 2010; Atlanta, USA. Abstract P01–02 [Internet]. [cited 2014 Oct 1]. Available from: .
    1. Ananworanich J, Chitwarakorn A, Wimonsate W, Varangrat A, Chaikummao S, Sriporn A, et al. HIV and syphilis infection among men who have sex with men – Bangkok, 2005–2011. Morb Mortal Wkly Rep. 2013;62:518–20.
    1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209–20. doi: 10.1056/NEJMoa0908492.
    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99. doi: 10.1056/NEJMoa1011205.
    1. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo controlled phase 3 trial. Lancet. 2013;381:2083–90. doi: 10.1016/S0140-6736(13)61127-7.
    1. HIV Prevention Trials Network (HPTN) HPTN 067. The ADAPT study. Durham, NC: HPTN; 2012.
    1. Microbicide Trials Network (MTN) MTN-017. Pittsburgh: MTN; 2013.
    1. van Griensven F, Ayutthaya P, Wilson E. HIV surveillance and prevention in transgender women. Lancet Infect Dis. 2013;13(3):185–6.
    1. Gooren LJ, Sungkaew T, Giltay EJ, Guadamuz TE. Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand. Cult Health Sex. 2015;17(1):92–103.
    1. Sineath RC, Finneran C, Sullivan P, Sanchez T, Smith DK, Griensven F, et al. Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand. J Int Assoc Provid AIDS Care. 2013;12(4):227–31.
    1. Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, Yotruean K, Saokhieo P, et al. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. PLoS One. 2013;8(10):e76650.
    1. Wheelock A, Eisingerich AB, Ananworanich J, Gomez GB, Hallett TB, Dybul MR, et al. Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One. 2013;8(1):e54288.
    1. Thienkrua W, Todd CS, Chaikummao S, Sukwicha W, Yafant S, Tippanont N, et al. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok. AIDS Care. 2014;26(11):1359–69.
    1. Treatment Action Group. U.S. Centers for Disease Control and Prevention (CDC) Sponsored HIV Preexposure Prophylaxis (PrEP) Trial among Thai Injection Drug Users Marred by Lack of Response to Community Concerns: Statement of Thai Drug Users Network (TDN), Thai AIDS Treatment Action Group (TTAG), and Treatment Action Group (TAG) [Internet] [cited 2014 Nov 2014]. Available from: .
    1. WHO. Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Geneva: WHO; 2014.
    1. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.
    1. Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Enrollment and preliminary follow-up of injecting drug users receiving pre-exposure prophylaxis in Bangkok; Conference on Retroviruses and Opportunistic Infections; 2015 Feb 23–26; Seattle, USA. Abstract number 971.
    1. Study to evaluate the feasibility of community-based test and treat strategies among men who have sex with men and transgender women to increase the uptake of HIV testing and treatment services in Thailand [Internet] [cited 2015 Mar 25]. Available from: .
    1. Evaluation of a facility-based test, treat, and prevent HIV program among men who have sex with men and transgender women in Thailand [Internet] [cited 2015 Mar 25]. Available from: .
    1. The World Bank. Thailand [Internet] [2014 Nov 17]. Available from: .
    1. National consultation on the strategic use of ARVs – Thailand. Meeting report. Bangkok: Ministry of Public Health; 2012. p. 27.
    1. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–77.
    1. Essentials of HIV/AIDS treatment and prevention 2014 [cited 2015 March 25] Thailand [Internet] Bureau of AIDS, TB and STIs, Department of Disease Control, Ministry of Public Health, Thailand Available from: [in Thai].
    1. World Health Organization. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva: WHO; 2012.
    1. Lo YR, Kato M, Phanuphak N, Fujita M, Duc DB, Sopheap S, et al. Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region. Sex Health. 2014;11(2):126–36.
    1. Jurgens R, Nowak M, Day M. HIV and incarceration: prisons and detention. J Int AIDS Soc. 2011;14:26.
    1. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, Des Jarlais DC, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15:397–405.
    1. Thaisri H, Lerwitworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, et al. HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis. 2003;3:25.
    1. Buavirat A, Page-Shafer K, van Griensven GJP, Mandel JS, Evans J, Chuaratanaphong J, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. Br Med J. 2003;326:308.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe